22nd Century Group Q3 Revenue: Tobacco and Cannabis Products

Nov.09.2022
22nd Century Group Q3 Revenue: Tobacco and Cannabis Products
22nd Century Group's Q3 revenue from tobacco products was $11.5 million, with a 47.7% increase from 2021. They also generated $7.8 million from cannabis-related products.

In the third quarter, 22nd Century Group's revenue from tobacco-related products reached $11.5 million, a 47.7% increase from 2021. This was mainly attributed to an increase in the number of boxes sold, price hikes, and a favorable combination of filtered cigars and cigarettes (including exported cigarettes).


The revenue from marijuana/marijuana-related products was $7.8 million, compared to $0 in the same quarter last year.


During this quarter, the company expanded its distribution of VLN nicotine-reducing cigarettes, accelerating sales in Colorado and Illinois, while also launching the brand in the "Four Corners" states of Arizona, Utah, and New Mexico.


In the past few months, 22nd Century has made significant progress in reducing nicotine in tobacco and the cannabis/marijuana industry," said James A. Mish, CEO of 22nd Century, in a statement. "Our VLN product release has expanded from a special pilot in Chicago to five states. We plan to expand this base to as many as 18 states in the next 12 months.


By doing so, we will be able to enter more than half of the $80 billion US tobacco market and put ourselves in a favorable position in most, if not all, states that have enacted MRTP (Modified Risk Tobacco Product) consumption tax provisions, benefiting our unique product authorization. Even capturing just 1% of the market share (which we believe is highly achievable based on our pilot results) would be a game-changer for our revenue stream.


The FDA continues to drive its interest in the transformative policy of reduced nicotine and menthol, and 22nd Century is at the forefront of this opportunity with our unique MRTP authorization for a 95% reduction in nicotine combustible cigarettes and years of clinical research backing the benefits of our product.


Statement:


This article is compiled based on information from third-party sources and is intended solely for industry exchanges and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry discussion and research.


Due to limitations in the translation process, the compiled article may not accurately convey the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau and Taiwan-related, as well as foreign-related, statements and stances.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts
Philip Morris and R.J. Reynolds Face Trial Over Woman’s Lung Cancer Death in Massachusetts
According to Law360, the family of Maria Petruzziello has taken Philip Morris and R.J. Reynolds to trial in Massachusetts, alleging the companies are responsible for her 2019 lung cancer death after decades of smoking. Plaintiffs argue her experience mirrors many smokers, while the defense points to her years-long cessation and personal choice.
Dec.03 by 2FIRSTS.ai
BAT appoints Matthew Wright as Independent Non-Executive Director, effective November 1, 2025
BAT appoints Matthew Wright as Independent Non-Executive Director, effective November 1, 2025
Matthew Wright appointed as independent non-executive director of British American Tobacco, effective November 1, bringing extensive international executive experience.
Oct.15 by 2FIRSTS.ai
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point
As regulations tighten, consumer habits evolve, and new nicotine products reshape the market, the cigar industry is undergoing a quiet but profound transformation. In this exclusive interview, 2Firsts speaks with Cigar Sense — a data-driven sensory analysis firm — to explore what’s really changing in cigars, and what it means for manufacturers, retailers, and smokers around the world.
Nov.10
Australia forms National Disruption Group to combat illicit tobacco and converging crime threats
Australia forms National Disruption Group to combat illicit tobacco and converging crime threats
Australia establishes new national task force to combat illegal tobacco market, led by Interior Minister Tony Burke.
Oct.20 by 2FIRSTS.ai
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.
Dec.04
Product | Differences in Configuration and Indicator Methods: Three UWELL G5 Series Devices Launch on U.S. and U.K. Channels
Product | Differences in Configuration and Indicator Methods: Three UWELL G5 Series Devices Launch on U.S. and U.K. Channels
UWELL has launched three models in its Caliburn G5 Lite series across U.S. and U.K. channels, using indicator lights or breathing lights to display device status. Compared with the earlier G4 series, the new G5 Lite lineup continues a screenless design and increases battery capacity to 1,600mAh. The three devices also share the same core specifications, including e-liquid capacity, maximum power output, and pod compatibility.
Dec.10 by 2FIRSTS.ai